Divi's Laboratories Ltd
BSE:532488
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Divi's Laboratories Ltd
BSE:532488
|
IN |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
IN |
|
C
|
Chien Shing Harbour Service Co Ltd
TWSE:8367
|
TW |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
TomCo Energy PLC
F:NI41
|
UK |
|
E
|
East Japan Railway Co
DUS:EJR
|
JP |
|
Mr Max Holdings Ltd
TSE:8203
|
JP |
|
D
|
Deutsche Telekom AG
F:DTE
|
DE |
|
C
|
Chesnara PLC
LSE:CSN
|
UK |
|
B
|
BP PLC
F:BSU
|
UK |
Intrinsic Value
Is DIVISLAB undervalued or overvalued?
See the intrinsic value estimate for Divi's Laboratories Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Divi's Laboratories Does
Divi’s Laboratories makes active pharmaceutical ingredients, or APIs, and pharmaceutical intermediates for other drugmakers. In simple terms, it is a behind-the-scenes supplier that helps pharmaceutical companies produce finished medicines. It also does custom synthesis work, where it develops and manufactures specific molecules for customers that need a reliable outside production partner.
- Headquarters
- India IN
- Employees
- 10 542
- IPO date
- Mar 12, 2003
Divi's Laboratories has a narrow economic moat
Replacing Divi’s in an established drug manufacturing program takes testing, process transfers and, where required, regulatory approval, making customers reluctant to move solely for a lower price. Its large production batches, refined manufacturing methods and in-house raw materials also help keep costs competitive in selected drug ingredients.
Read the full moat analysis
Revenue & Expenses Breakdown
Divi's Laboratories Ltd
Earnings Waterfall
Divi's Laboratories Ltd
The intrinsic value for Divi's Laboratories Ltd (532488) under the Base Case is hidden INR.
Compared with the current market price of 10 150 INR, the stock appears hidden.
